Full Text View
Tabular View
No Study Results Posted
Related Studies
Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT (Alloforb)
This study is currently recruiting participants.
Study NCT00624754   Information provided by Assistance Publique - Hôpitaux de Paris
First Received: February 15, 2008   Last Updated: March 31, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obstructive Airway Disease
Additional conditions recognized in this trial
Bronchiolitis
Bronchiolitis Obliterans
Lung Diseases, Obstructive
More general conditions related to this trial
Bronchial Diseases
Bronchitis
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Formoterol/Budesonide
lactose
Additional drug interventions recognized in this trial
Budesonide
Formoterol
Symbicort
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services